Zentalis Pharmaceuticals (ZNTL) Amortizatization of Intangibles (2020 - 2026)

Zentalis Pharmaceuticals' Amortizatization of Intangibles history runs 7 years deep, the most recent figure standing at $224000.0 for Q1 2026.

• In Q1 2026, Amortizatization of Intangibles fell 78.34% year-over-year to $224000.0; the TTM figure through Mar 2026 stood at $2.0 million (down 68.86% YoY), while the FY2025 annual figure was $2.8 million, down 65.47% from the prior year.
• Amortizatization of Intangibles for Q1 2026 stood at $224000.0, down from $431000.0 in the prior quarter.
• The five-year high for Amortizatization of Intangibles was $4.6 million in Q4 2023, with the low at -$146000.0 in Q1 2022.
• The 5-year median for Amortizatization of Intangibles is $1.4 million (2024), against an average of $1.6 million.
• The sharpest annual moves came in 2022 and 2023: Amortizatization of Intangibles slumped 150.52% in 2022, then surged 2397.67% in 2023.
• Zentalis Pharmaceuticals' Amortizatization of Intangibles stood at $2.5 million in 2022, then surged by 83.97% to $4.6 million in 2023, then plunged by 69.33% to $1.4 million in 2024, then sank by 69.15% to $431000.0 in 2025, then sank by 48.03% to $224000.0 in 2026.
• Business Quant data shows ZNTL's Amortizatization of Intangibles at $224000.0 in Q1 2026, $431000.0 in Q4 2025, and $517000.0 in Q3 2025.